NCNikky Corthout

Nikky Corthout

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nikky Corthout has a total of 151 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hybrid Emulsions for the Efficient Formation of Giant Unilamellar Vesicles

    by Jiangyu Gan, Timen Mooren, Zhiyuan Ma, Špela Lemež, Willemien Gosselé, Nikky Corthout, Damya Laoui, Hojjat Alizadeh Zeinabad, Xavier Casadevall i Solvas

    Droplet-templated production of giant unilamellar vesicles (GUVs) (mediated by either nanoparticles or surfactants) offers an emergent platform for the bottom-up assembly of synthetic cells. Currently, these techniques suffer from inherent efficacy and scalability challenges, which hinder the possibility to generate biologically relevant vesicles (i.e., supporting transmembrane proteins) for therapeutic applications. Here, we report on a novel methodology that harnesses synergistic effects of hybrid emulsions (i.e., combining fluorosurfactants with fluorinated silica nanoparticles, FSiNPs) to modulate the interfacial stability of the generated emulsions, allowing for a more nuanced and efficient production of GUVs via the droplet-templated technique. Droplets formed with FSiNPs in combination with three structurally different copolymeric fluorosurfactants (a monoblock, a diblock, and a triblock) display a diversity of effects, some of which synergize with the processes of GUV formation and release. The monoblock Krytox-FSH surfactant (consisting of a carboxylic hydrophilic group linked to a perfluoropolyether moiety, PFPE) appears to adsorb on the surface of FSiNPs, enhancing emulsion stability and hindering GUV release. The previously reported diblock surfactant FSL-PEGMMA360 competitively excludes FSiNPs from the interface, preventing GUV formation altogether. Intriguingly, the triblock surfactant RAN-008 (PEG600-PFPE2) displays a synergistic effect with FSiNPs, which permits GUV assembly while facilitating GUV release. Mechanistic studies using calcein release from GUV-precursor liposomes and fluorescence lifetime imaging microscopy–Förster resonance energy transfer (FLIM-FRET) suggest that this effect may arise from a moderate steric hindrance role of RAN-008 against FSiNPs, which weakens the affinity of the newly formed GUVs for the FSiNPs stabilized at the droplet interface. We further demonstrate that this method is more suitable for preparing GUVs incorporating transmembrane proteins than previously reported droplet-templated techniques. Our results indicate that subtle changes in the interfacial structure of complex amphiphilic systems can drastically impact emulsion stability and their interactions with the proteolipidic components of the dispersed phase, potentially providing optimal conditions for droplet-templated GUV formation.

  • Open Access

    Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity

    by Oyindamola Christiana Adebayo, Ilhem Dallali, Sara Kerselaers, Sergio Gimeno-Rocafort, Sandra Van Aerschot, Annelies Janssens, Tjessa Bondue, Charlotte Cresens, Nnamdi Joseph Asouzu, Nikky Corthout, et al.

    Key Points: Apolipoprotein L1 variants were transported to the plasma membrane via actin filaments, where they exhibited distinct dynamics. Apolipoprotein L1 was functionally expressed at the plasma membrane and formed a voltage-dependent non-selective cation-permeable pore. Influx of calcium from the extracellular medium was the primary origin of the increased cytosolic calcium crucial for Apolipoprotein L1 cytotoxicity. Background: The mechanisms by which apolipoprotein L1 ( APOL1 ) risk variants, G1 and G2, induce kidney disease in individuals of African ancestry remain contentious. Methods: In this study, we utilized a heterologous expression system of HEK-293 cells and human podocytes to investigate APOL1-mediated cytotoxicity using genetic, electrophysiological, and microscopy-based approaches. Results: APOL1 variants showed dynamic transport in vesicle-like structures toward the plasma membrane via actin filaments. At the plasma membrane, the non-risk APOL1 G0 and risk variants formed non-selective cation-permeable pores for Na + and Ca 2+ , exhibiting functional activity under basal conditions. Extracellular Ca 2+ was identified as the primary source of Ca 2+ influx through APOL1, leading to cytotoxicity. APOL1 risk variants exhibited increased basal channel activity compared to non-risk APOL1 G0, resulting in haplotype-dependent cytotoxicity. Furthermore, we observed that both the M1 (N264K) variant and APOL1 inhibitor, Inaxaplin, exerted protective effects on cell viability by blocking the APOL1-dependent intracellular Ca 2+ influx. Conclusions: This study demonstrated APOL1 to be a membrane protein involved in the influx of Ca 2+ from the extracellular medium. Increased activity of APOL1 led to markedly increased cytotoxicity, which supports the gain-of-function theory. This effect was prevented by the presence of N264K variant or treatment with the APOL1 inhibitor, Inaxaplin.


  • Open Access

    Axonal Eif5a hypusination controls local translation and mitigates defects in FUS-ALS

    by Diana Piol, Bilal Khalil, Tessa Robberechts, Theo Killian, Maria Georgopoulou, Gabriele Partel, David Wouters, Nikolai Hecker, Paraskevi Tziortzouda, Yana Verresen, et al.

    Local protein synthesis is vital for neuronal function, but its dysregulation in neurodegenerative diseases remains poorly defined. Here we applied spatial transcriptomics to adult mouse motor nerve axons and cell bodies to enable subcellular mapping. Among transcripts found in mature axons, the most enriched biological process is protein translation, and localization of translation machinery was confirmed using multiplexed single-molecule spatial transcriptomics combined with immunofluorescence. Amyotrophic lateral sclerosis (ALS)-associated mutations in the RNA-binding protein fused in sarcoma (FUS), which suppress local translation, disrupt the compartment-specific RNA signatures, including components of the translation machinery. In particular, eukaryotic initiation factor 5a (Eif5a), a translation factor involved in elongation and termination, is found to be locally impaired in mutant FUS axons with reduced levels of its active hypusinated form. Axon-specific treatment with polyamine spermidine restores Eif5a hypusination and ameliorates mutant FUS-dependent neuronal defects, including suppression of local protein synthesis. Finally, in vivo spermidine treatment reduces ALS-related toxicity in mutant FUS and TDP-43 Drosophila models, which may have implications for therapy development.


  • Open Access

    Presenilin-2 interacts with Lamtor1 at late endosome/lysosome-endoplasmic reticulum contact sites to guard endolysosomal homeostasis

    by Wim Annaert, Céline Vrancx, Ragna Sannerud, Rosanne Wouters, Iván Ramos Calvo, Anika Perdok, Rosanna Poll, Nikky Corthout, Xiaojuan Yang, Ruben Hellemans, et al.

    Mutations in Presenilin-2 (PSEN2), a catalytic subunit of the γ-secretase complex, cause familial Alzheimer’s disease (AD). Beyond its role in β-amyloid generation, we hypothesized that PSEN2 also supports key cellular functions whose disruption may underlie neuronal vulnerability. We now demonstrate that PSEN2 in late endosomes/lysosomes (LE/Lys) specifically localizes at contact sites with the endoplasmic reticulum (ER), implicating it in inter-organellar communication. Using proximity-dependent biotinylation of APEX2-tagged PSEN2, we defined its local interactome and identified a novel interaction with Lamtor1 –a regulator of vesicle trafficking and mTORC1 signaling– within LE/Lys-ER contacts. Mechanistically, altered PSEN2 expression disrupted Lamtor1-dependent signaling, promoting the recruitment of the BORC complex at LE/Lys, thereby driving their repositioning, while also affecting nutrient-dependent mTORC1 activity. These findings are recapitulated in mouse hippocampal neurons, uncovering a novel role for PSEN2 in maintaining organelle homeostasis with relevance to early events in AD pathogenesis.

  • Open Access

    Soma-localized Rab39 inhibits synaptic autophagy by controlling trafficking of Atg9 vesicles

    by Ayse Kilic, Gokhan Ozturan, Dirk Vandekerkhove, Sabine Kuenen, Jef Swerts, Esther Muñoz Pedrazo, Carles Calatayud Aristoy, Abril Escamilla Ayala, Nikky Corthout, Pablo Hernández Varas, et al.

    Presynaptic terminals can be located far from the neuronal cell body and are thought to independently regulate protein and organelle turnover. Autophagy is a critical process for maintaining proteostasis, and its synaptic dysregulation is associated with neurodegenerative diseases. In this work, we report a soma-centered mechanism that regulates autophagy-controlled protein turnover at distant presynaptic terminals in Drosophila . We show that a central component of this system is Rab39, whose human homolog RAB39B is mutated in Parkinson’s disease. Although Rab39 is localized in the soma, its loss of function or a human pathogenic mutation causes increased autophagy at presynaptic terminals, resulting in faster synaptic protein turnover and dopaminergic synapse degeneration. Using a large-scale unbiased genetic modifier screen, we identified genes encoding cytoskeletal and axonal organizing proteins, including Shortstop (Shot), as suppressors of synaptic autophagy. We demonstrate that active Rab39 selectively controls Shot- and Unc104/KIF1A-mediated delivery of autophagy-related Atg9-positive vesicles to synapses. Our findings suggest that Rab39-mediated trafficking in the soma orchestrates a cross-compartmental mechanism that regulates the levels of autophagy at synapses.


  • Open Access

    Soma-centered control of synaptic autophagy by Rab39-regulated anterograde trafficking of Atg9

    by Ayse Kilic, Dirk Vandekerkhove, Sabine Kuenen, Jef Swerts, Esther Muñoz Pedrazo, Carles Calatayud Aristoy, Abril Escamilla Ayala, Nikky Corthout, Pablo Hernández Varas, Stephane Plaisance, et al.

    Presynaptic terminals can be located far from the neuronal cell body and are thought to independently regulate protein and organelle turnover. In this work, we report a soma-centered mechanism that regulates autophagy-driven protein turnover at distant presynaptic terminals in Drosophila . We show that this system is regulated by Rab39, whose human homolog is mutated in Parkinson’s disease. Although Rab39 is localized in the soma, its loss of function causes increased autophagy at presynaptic terminals, resulting in faster synaptic protein turnover and neurodegeneration. Using a large-scale unbiased genetic modifier screen, we identified genes encoding cytoskeletal and axonal organizing proteins, including Shortstop ( Shot ), as suppressors of synaptic autophagy. We demonstrate that Rab39 controls Shot-and Unc104/KIF1a-mediated transport of autophagy-related Atg9 vesicles to synapses. Under starvation conditions, Rab39 in the soma shifts its localization from endosomes to lysosomes, thereby controlling the availability of Atg9 vesicles for trafficking to synapses. Our findings indicate that Rab39-mediated trafficking in the soma orchestrates a cross-compartmental mechanism that regulates the abundance of autophagy at synapses.


  • Open Access

    Nova-ST: Nano-Patterned Ultra-Dense platform for spatial transcriptomics

    by Suresh Poovathingal, Kristofer Davie, Roel Vandepoel, Nicholas Poulvellarie, Annelien Verfaillie, Nikky Corthout, Stein Aerts

    Spatial transcriptomics workflows using barcoded capture arrays are commonly used for resolving gene expression in tissues. However, existing techniques are either limited by capture array density or are cost prohibitive for large scale atlasing. We present Nova-ST, a dense nano-patterned spatial transcriptomics technique derived from randomly barcoded Illumina sequencing flow cells. Nova-ST enables customized, low cost, flexible, and high-resolution spatial profiling of large tissue sections. Benchmarking on mouse brain sections demonstrates significantly higher sensitivity compared to existing methods, at reduced cost. Motivation: Spatial transcriptomics analysis is becoming exceedingly important in biomedical and clinical research. Several platforms for spatial transcriptomics are currently available, but most of these technologies are commercialized making them inflexible and cost prohibitive. The motivation for this work was to establish an open source, flexible and sensitive sequencing-based spatial transcriptomics platform that can provide a considerable cost advantage for performing large scale spatial profiling. We provide thorough and in-depth guidance and resources both for the experimental and computational components of the workflow, to facilitate easy implementation of Nova-ST.


  • Open Access

    All‐in‐Human Target Discovery in Alzheimer’s Disease and Resilient Brains

    by A Martirosyan, W‐T Chen, A Lu, D S Garcia, K Craessaerts, M Vanheusden, L de Vries, B Pavie, N Corthout, V van Lieshout, et al.

    Background: Alzheimer’s disease (AD) is characterized by neuropathological hallmarks including amyloid plaques and tau tangles and neurodegeneration in the frontal cortex. While there is a strong association of tau pathology with neurodegeneration and cognitive decline, around 30% of amyloid plaque‐carrying seniors remain cognitively healthy. We hypothesize that protective cellular mechanisms upstream of tau phosphorylation and neurodegeneration may underlie this resilience.Method: We applied high resolution spatial transcriptomics and single nuclei RNA sequencing on postmortem frontal lobes from 10 demented and 10 non‐demented individuals with comparable degrees of amyloid pathology. We integrated the generated transcriptomics data with proteomics, genomics and drug action databases and interpret cellular transcriptome responses to pathology in the context of human specific protein‐protein interaction networks.Result: Using spatial and single nuclei transcriptomics, we identify specific transcriptomic signatures and regulatory networks in cellular microenvironments around amyloid plaques and pTau pathology niches. Our results suggest that specific neuronal and glial subpopulations carry enriched vulnerability towards amyloid plaque and pTau depositions. We further find that certain cell death signaling pathways related to neurodegeneration are overrepresented in the context of pTau pathology. Finally, our multi‐omics database integration approach has led to the identification of potential drug targets for therapeutics addressing cellular mechanisms of neuroprotection.Conclusion: Spatial transcriptomics from human brain tissue is a powerful approach to reveal cellular mechanisms of pathogenic lesions and enables us to identify neuroprotective mechanisms that may prevent the development of tauopathy and ultimately neuronal loss. The combination of single cell and spatial transcriptomics together with protein‐protein interaction networks provides a promising approach for the identification of novel therapeutic targets for AD.

  • Class A capsid assembly modulator RG7907 clears HBV-infected hepatocytes through core-dependent hepatocyte death and proliferation

    by Dieudonné Buh Kum, Hannah Vanrusselt, Abel Acosta Sanchez, Valerio Taverniti, Eloi R. Verrier, Thomas F. Baumert, Cheng Liu, Jerome Deval, Nikky Corthout, Sebastian Munck, et al.

    Background and Aims: Effective therapies leading to a functional cure for chronic hepatitis B are still lacking. Class A capsid assembly modulators (CAM-As) are an attractive modality to address this unmet medical need. CAM-As induce aggregation of the HBV core protein (HBc) and lead to sustained HBsAg reductions in a chronic hepatitis B mouse model. Here, we investigate the underlying mechanism of action for CAM-A compound RG7907. Approach and Results: RG7907 induced extensive HBc aggregation in vitro, in hepatoma cells, and in primary hepatocytes. In the adeno-associated virus (AAV)–HBV mouse model, the RG7907 treatment led to a pronounced reduction in serum HBsAg and HBeAg, concomitant with clearance of HBsAg, HBc, and AAV-HBV episome from the liver. Transient increases in alanine transaminase, hepatocyte apoptosis, and proliferation markers were observed. These processes were confirmed by RNA sequencing, which also uncovered a role for interferon alpha and gamma signaling, including the interferon-stimulated gene 15 (ISG15) pathway. Finally, the in vitro observation of CAM-A–induced HBc–dependent cell death through apoptosis established the link of HBc aggregation to in vivo loss of infected hepatocytes. Conclusions: Our study unravels a previously unknown mechanism of action for CAM-As such as RG7907 in which HBc aggregation induces cell death, resulting in hepatocyte proliferation and loss of covalently closed circular DNA or its equivalent, possibly assisted by an induced innate immune response. This represents a promising approach to attain a functional cure for chronic hepatitis B.


  • Top Cited Papers

    Mitochondria metabolism sets the species-specific tempo of neuronal development

    by Ryohei Iwata, Pierre Casimir, Emir Erkol, Leïla Boubakar, Mélanie Planque, Isabel M. Gallego López, Martyna Ditkowska, Vaiva Gaspariunaite, Sofie Beckers, Daan Remans, et al.

    Neuronal development in the human cerebral cortex is considerably prolonged compared with that of other mammals. We explored whether mitochondria influence the species-specific timing of cortical neuron maturation. By comparing human and mouse cortical neuronal maturation at high temporal and cell resolution, we found a slower mitochondria development in human cortical neurons compared with that in the mouse, together with lower mitochondria metabolic activity, particularly that of oxidative phosphorylation. Stimulation of mitochondria metabolism in human neurons resulted in accelerated development in vitro and in vivo, leading to maturation of cells weeks ahead of time, whereas its inhibition in mouse neurons led to decreased rates of maturation. Mitochondria are thus important regulators of the pace of neuronal development underlying human-specific brain neoteny.